| Net income |
132M |
| Depreciation and amortization |
244M |
| (Decrease) increase in net liabilities from price risk management activities |
-59M |
| Regulatory deferral - price risk management activities |
| Deferred income taxes |
18M |
| Regulatory deferral of settled derivative instruments |
| Power cost deferrals, net |
| Renewable adjustment clause deferrals |
| Senate Bill 408 deferrals, net |
| Allowance for equity funds used during construction |
-19M |
| Decoupling mechanism deferrals, net |
| Other non-cash income and expenses, net |
8M |
| Decrease in receivables |
53M |
| Decrease (increase) in margin deposits, net |
25M |
| Income tax refund received |
0 |
| Decrease in payables |
31M |
| Other working capital items, net |
12M |
| Contribution to pension plan |
| Other, net |
-29M |
| Net cash provided by operating activities |
497M |
| Capital expenditures |
-454M |
| Sales of Nuclear decommissioning trust securities |
17M |
| Purchases of Nuclear decommissioning trust securities |
-16M |
| Distribution from Nuclear decommissioning trust |
| Other, net |
-1M |
| Net cash used in investing activities |
-454M |
| Proceeds from issuance of long-term debt |
265M |
| Payments on long-term debt |
-133M |
| Borrowings on short-term debt |
| Payments on commercial paper, net |
| Dividends paid |
-82M |
| Debt issuance costs |
| Noncontrolling interests’ capital distributions |
| Net cash (used in) provided by financing activities |
41M |
| Increase in cash and cash equivalents |
84M |
| Cash and cash equivalents, beginning of period |
4M |
| Cash and cash equivalents, end of period |
88M |
| Cash paid for interest, net of amounts capitalized |
61M |
| Cash paid for income taxes |
12M |
| Accrued capital additions |
| Accrued dividends payable |
| Preliminary engineering transferred to construction work in progress from Other noncurrent assets |
